News & Updates
Filter by Specialty:
Drug monitoring may prevent weight gain in ASD patients taking aripiprazole
A recent study exploring the relationship between aripiprazole pharmacokinetics (PK), side effects, and effectiveness in children and adolescents with autism spectrum disorder (ASD) has found that higher plasma levels correlate with greater weight gain.
Drug monitoring may prevent weight gain in ASD patients taking aripiprazole
27 Sep 2023
Depression, diabetes duration predict sexual dysfunction in women with T1D
Type 1 diabetes (T1D) is significantly associated with the risk of sexual dysfunction among women, according to the results of a systematic review and meta-analysis.
Depression, diabetes duration predict sexual dysfunction in women with T1D
23 Sep 2023
Zuranolone improves symptoms in adults with major depressive disorder
Treatment with zuranolone 50 mg/day in adults with major depressive disorder (MDD) results in greater improvements in depressive symptoms at day 15, demonstrating a rapid time to effect (day 3), and is generally well tolerated, with no new safety concerns compared with lower dosages, reports a study.
Zuranolone improves symptoms in adults with major depressive disorder
21 Sep 2023
Zuranolone safe, effective for postpartum depression
Use of zuranolone significantly improves depressive symptoms, with no serious side effects, in women with severe postpartum depression (PPD), a common perinatal complication with adverse maternal and infant outcomes, results of a phase III trial have shown.
